Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Fresenius Medical Care stock price, quote, forecast and news

FME.DE
DE0005785802
578580

Price

37.34 EUR
Today +/-
+0 EUR
Today %
+0 %
P

Fresenius Medical Care Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Fresenius Medical Care, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Fresenius Medical Care from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Fresenius Medical Care’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Fresenius Medical Care. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Fresenius Medical Care’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Fresenius Medical Care’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Fresenius Medical Care’s growth potential.

Fresenius Medical Care Revenue, EBIT and net profit per share

DateFresenius Medical Care RevenueFresenius Medical Care EBITFresenius Medical Care Net Income
2030e26.17 B EUR2.7 B EUR0 EUR
2029e23.68 B EUR2.6 B EUR1.72 B EUR
2028e23.5 B EUR2.76 B EUR1.53 B EUR
2027e22.93 B EUR2.68 B EUR1.48 B EUR
2026e21.42 B EUR2.34 B EUR1.21 B EUR
2025e20.58 B EUR2.09 B EUR1.04 B EUR
2024e19.81 B EUR1.74 B EUR828.74 M EUR
202319.45 B EUR1.28 B EUR499 M EUR
202219.4 B EUR1.29 B EUR673.41 M EUR
202117.62 B EUR1.78 B EUR969.31 M EUR
202017.86 B EUR2.24 B EUR1.16 B EUR
201917.48 B EUR2.29 B EUR1.2 B EUR
201816.55 B EUR2.31 B EUR1.98 B EUR
201717.78 B EUR2.54 B EUR1.28 B EUR
201616.57 B EUR2.35 B EUR1.14 B EUR
201515.45 B EUR2.1 B EUR954.95 M EUR
201412.14 B EUR1.67 B EUR781.34 M EUR
201311.22 B EUR1.66 B EUR811 M EUR
201210.96 B EUR1.68 B EUR920 M EUR
20119.19 B EUR1.48 B EUR776 M EUR
20109.09 B EUR1.45 B EUR742 M EUR
20098.07 B EUR1.26 B EUR636 M EUR
20087.23 B EUR1.15 B EUR557 M EUR
20077.13 B EUR1.17 B EUR531 M EUR
20066.77 B EUR1.02 B EUR427 M EUR
20055.45 B EUR756 M EUR365 M EUR
20045.01 B EUR686 M EUR322 M EUR

Fresenius Medical Care Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B EUR)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B EUR)EBIT (B EUR)EBIT MARGIN (%)NET INCOME (B EUR)NET INCOME GROWTH (%)DIV. (EUR)DIV. GROWTH (%)SHARES (M)DOCUMENTS
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e2030e
0.691.22.883.133.614.565.435.394.895.015.456.777.137.238.079.099.1910.9611.2212.1415.4516.5717.7816.5517.4817.8617.6219.419.4519.8120.5821.4222.9323.523.6826.17
-72.77140.538.4315.3826.3919.04-0.66-9.292.498.7224.225.241.4711.5512.721.1119.222.348.2827.267.217.33-6.965.622.19-1.3510.100.281.863.864.087.062.490.7410.54
42.6541.3740.6737.1036.8634.9133.7332.5733.0833.4934.4433.8634.6234.3234.1134.3435.3834.6533.7132.8533.5033.8933.8431.1530.8731.0027.0925.2225.32-------
0.30.51.171.161.331.591.831.761.621.681.882.292.472.482.753.123.253.83.783.995.185.626.025.155.45.544.774.894.930000000
0.10.150.320.440.530.670.710.740.670.690.761.021.171.151.261.451.481.681.661.672.12.352.542.312.292.241.781.291.281.742.092.342.682.762.62.7
13.6912.5911.2013.9414.6114.7813.1213.6713.7013.6813.8715.0416.4515.9215.6015.9516.0615.3514.7713.7313.5914.1814.2713.9713.0912.5410.096.636.578.7610.1710.9111.7011.7510.9610.33
0.050.070.080.01-0.230.230.070.310.290.320.370.430.530.560.640.740.780.920.810.780.951.141.281.981.21.160.970.670.50.831.041.211.481.531.720
-29.6314.29-83.75-1,892.31-198.28-69.87343.48-4.9010.6513.3516.9924.364.9014.1816.674.5818.56-11.85-3.7022.1519.8111.9054.89-39.48-2.92-16.75-30.55-26.0066.2725.4816.3622.253.6512.47-
------------------------------------
------------------------------------
106133230237237268289289289290293296297298298302305307305302.87305.27306.7307.64307.28302.69294.06292.94293.25293.410000000
------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Fresenius Medical Care Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Fresenius Medical Care is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M EUR)RECEIVABLES (M EUR)OTHER REC. (M EUR)INVENTORIES (M EUR)OTHER CURRENT LIAB. (M EUR)CURRENT ASSETS (M EUR)TANGIBLE ASSETS (M EUR)LONG-T. INVEST. (M EUR)LONG-T. REC. (M EUR)INTANGIBLE ASSETS (M EUR)GOODWILL (M EUR)OTHER NON-CURRENT ASSETS (M EUR)NON-CURRENT ASSETS (M EUR)TOTAL ASSETS (M EUR)LIABILITIESCOMMON STOCK (M EUR)ADDITIONAL PAID-IN CAPITAL (M EUR)RETAINED EARNINGS (M EUR)OTHER EQUITY (M EUR)UNREAL. GAINS/LOSSES (M EUR)EQUITY (M EUR)LIABILITIES (M EUR)PROVISIONS (M EUR)OTHER SHORT-TERM LIAB. (M EUR)SHORT-TERM DEBTS (M EUR)LONG-TERM DEBT PORTION (M EUR)SHORT-TERM REC. (M EUR)LONG-T. LIAB. (M EUR)DEFERRED TAXES (M EUR)OTHER LIAB. (M EUR)LONG-T. LIABILITIES (M EUR)DEBT (M EUR)TOTAL CAPITAL (M EUR)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Fresenius Medical Care provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Fresenius Medical Care's financial health and stability.

Assets

Fresenius Medical Care's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Fresenius Medical Care must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Fresenius Medical Care after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Fresenius Medical Care's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B EUR)DEPRECIATION (B EUR)DEFERRED TAXES (M EUR)CHANGES IN WORKING CAPITAL (M EUR)NON-CASH ITEM (M EUR)PAID INTEREST (M EUR)PAID TAXES (M EUR)NET CASH FLOW FROM OPERATING ACTIVITIES (B EUR)CAPITAL EXPENDITURES (M EUR)CASH FLOW FROM INVESTING ACTIVITIES (M EUR)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M EUR)INTEREST INCOME AND EXPENSES (M EUR)NET DEBT CHANGE (B EUR)NET CHANGE IN EQUITY (M EUR)CASH FLOW FROM FINANCING ACTIVITIES (B EUR)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M EUR)TOTAL DIVIDENDS PAID (M EUR)NET CHANGE IN CASH FLOW (B EUR)FREE CASH FLOW (M EUR)SHARE-BASED COMPENSATION (M EUR)
19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.050.070.080.02-0.230.230.070.310.290.320.370.430.530.560.690.810.851.030.920.941.211.421.552.231.441.441.220.890.73
0.030.080.240.250.270.320.360.220.190.190.20.250.270.280.330.380.40.470.490.530.650.70.740.721.591.791.621.841.75
-2-31121-8483-51628027-3812103186106552087-360-203896411167-41-122
-29-58-114-148294-21091-23100126-365512-303-102-179-275135116-229-45-162231-153-833685-652-65064
00-11008642141210-1454482416-49-104-1525-9-27-126-824304215232126201
033130185202241245220184162145301297242238199186272282286342349339311470379341350394
0578-1264870134125160306337254233305392327430408519493541674358387301345334410
0.050.090.220.240.330.420.470.580.670.670.540.720.880.690.961.031.041.591.531.351.771.932.192.062.574.232.492.172.63
-71-98-202-141-150-247-307-253-257-224-253-372-424-468-412-395-429-525-572-719-888-942-970-1,142-1,162-1,085-886-770-710
-4669-577-250-239-522-522-298-326-293-340-3,378-567-604-500-847-1,661-1,715-907-1,979-901-1,246-991-245-3,285-1,334-1,196-734-544
25167-375-108-88-275-215-44-68-69-86-3,006-143-136-88-452-1,231-1,189-335-1,259-13-303-20897-2,123-249-30935166
00000000000000000000000000000
0.02-0.680.18-0.51-0.01-0.08-0.310.19-0.01-0.410.062.40.010.21-0.01-0.080.770.87-0.150.94-0.3-0.21-0.310.160.32-1.27-0.36-1.12-1.19
0335153016057-398126443282950836795-274808547-1010-583-3536200
-0.01-0.110.330.01-0.070.170.05-0.28-0.37-0.36-0.182.69-0.25-0.09-0.41-0.020.590.34-0.620.63-0.91-0.52-0.8-0.68-0.47-2.66-1.02-1.62-1.86
-222340568-16-2984245-262143-193369-152-173-272159-55-41229-163-457-110-185-528153-693-279-123-340
000-43-45-55-73-81-95-98-110-122-138-160-172-182-196-209-230-232-236-244-293-324-354-351-392-395-328
00.04-0.02-0.0100.03-00-0.010.010.020.060.05-0.010.050.18-0.040.17-0.030.03-0.020.20.271.17-1.140.070.4-0.210.15
-18.4-12.214.897.5179.1177.1166.5329.6409.6442286.1351452.3221.9548.5636.96061,061.5960635.1878.37989.281,220.98919.531,404.193,147.921,602.781,397.041,917.84
00000000000000000000000000000

Fresenius Medical Care stock margins

The Fresenius Medical Care margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fresenius Medical Care. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fresenius Medical Care.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Fresenius Medical Care's sales revenue. A higher gross margin percentage indicates that the Fresenius Medical Care retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Fresenius Medical Care's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Fresenius Medical Care's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Fresenius Medical Care's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Fresenius Medical Care. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Fresenius Medical Care's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Fresenius Medical Care Margin History

Fresenius Medical Care Gross marginFresenius Medical Care Profit marginFresenius Medical Care EBIT marginFresenius Medical Care Profit margin
2030e25.32 %10.33 %0 %
2029e25.32 %10.96 %7.28 %
2028e25.32 %11.75 %6.52 %
2027e25.32 %11.7 %6.45 %
2026e25.32 %10.91 %5.65 %
2025e25.32 %10.17 %5.05 %
2024e25.32 %8.76 %4.18 %
202325.32 %6.57 %2.57 %
202225.23 %6.63 %3.47 %
202127.09 %10.1 %5.5 %
202031.01 %12.55 %6.52 %
201930.87 %13.1 %6.86 %
201831.15 %13.97 %11.98 %
201733.84 %14.27 %7.2 %
201633.89 %14.19 %6.9 %
201533.5 %13.59 %6.18 %
201432.85 %13.73 %6.43 %
201333.71 %14.77 %7.23 %
201234.65 %15.35 %8.39 %
201135.38 %16.06 %8.44 %
201034.34 %15.95 %8.16 %
200934.11 %15.6 %7.89 %
200834.32 %15.92 %7.7 %
200734.62 %16.45 %7.45 %
200633.86 %15.04 %6.31 %
200534.44 %13.87 %6.7 %
200433.49 %13.68 %6.42 %

Fresenius Medical Care Stock Sales Revenue, EBIT, Earnings per Share

The Fresenius Medical Care earnings per share therefore indicates how much revenue Fresenius Medical Care has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Fresenius Medical Care earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Fresenius Medical Care's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Fresenius Medical Care’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Fresenius Medical Care's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Fresenius Medical Care Revenue, EBIT and net profit per share

DateFresenius Medical Care Sales per ShareFresenius Medical Care EBIT per shareFresenius Medical Care Earnings per Share
2030e89.2 EUR0 EUR0 EUR
2029e80.7 EUR0 EUR5.88 EUR
2028e80.1 EUR0 EUR5.22 EUR
2027e78.16 EUR0 EUR5.04 EUR
2026e73 EUR0 EUR4.12 EUR
2025e70.14 EUR0 EUR3.54 EUR
2024e67.53 EUR0 EUR2.82 EUR
202366.3 EUR4.36 EUR1.7 EUR
202266.15 EUR4.39 EUR2.3 EUR
202160.14 EUR6.07 EUR3.31 EUR
202060.73 EUR7.62 EUR3.96 EUR
201957.74 EUR7.56 EUR3.96 EUR
201853.85 EUR7.52 EUR6.45 EUR
201757.81 EUR8.25 EUR4.16 EUR
201654.03 EUR7.66 EUR3.73 EUR
201550.63 EUR6.88 EUR3.13 EUR
201440.1 EUR5.51 EUR2.58 EUR
201336.77 EUR5.43 EUR2.66 EUR
201235.7 EUR5.48 EUR3 EUR
201130.14 EUR4.84 EUR2.54 EUR
201030.1 EUR4.8 EUR2.46 EUR
200927.06 EUR4.22 EUR2.13 EUR
200824.26 EUR3.86 EUR1.87 EUR
200723.99 EUR3.95 EUR1.79 EUR
200622.87 EUR3.44 EUR1.44 EUR
200518.6 EUR2.58 EUR1.25 EUR
200417.29 EUR2.37 EUR1.11 EUR

Fresenius Medical Care business model

Fresenius Medical Care AG is a globally leading company in the field of dialysis and kidney care. The company was founded in 1996 when Fresenius AG merged its dialysis business with the US company National Medical Care (NMC). Today, Fresenius Medical Care operates in over 120 countries and employs around 120,000 people. The company operates more than 3,900 dialysis centers worldwide and serves approximately 345,000 dialysis patients. The business model of Fresenius Medical Care aims to improve the lives of patients with chronic kidney diseases by offering high-quality dialysis treatments, kidney care products, and treatment technologies. Fresenius Medical Care provides its patients with a comprehensive range of products and services that range from diagnosis to treatment and enable individualized patient care. A core competency of Fresenius Medical Care is the development and manufacture of dialysis products and technologies. The company offers a wide range of dialysis machines and accessories that can be used to support dialysis care in hospitals, clinics, and dialysis centers. In addition, the company offers medical solutions tailored to the needs of dialysis patients, including artificial kidneys, dialysis filters, and other medical devices. Fresenius Medical Care also conducts extensive research and development activities to develop innovative technologies as well as products and services that can improve the lives of dialysis patients. In terms of diagnostic products, Fresenius Medical Care offers a variety of laboratory and testing solutions that are used to monitor dialysis patients and ensure timely diagnosis of complications and infections. The company also offers a comprehensive range of medical devices and accessories that can be used to support patients in home dialysis. Fresenius Medical Care operates in three business segments: dialysis products, dialysis services, and hospital products. In the dialysis products segment, the company is engaged in the development, manufacture, and distribution of dialysis machines and accessories. In the dialysis services segment, the company operates a variety of dialysis centers and provides dialysis treatments performed by a multidisciplinary team of professionals. The company also operates a network of laboratories that offer diagnostic solutions for dialysis patients. In the hospital products segment, Fresenius Medical Care offers a variety of medical devices and solutions that help improve the clinical care of patients, including apheresis systems, infusion systems, and patient monitors. Throughout its history, Fresenius Medical Care has received numerous awards and recognitions, including the Innovation Award of the state of Baden-Württemberg for the development of an automated dialysis machine that enables better treatment of dialysis patients through the combination of online monitoring systems and intelligent algorithms. Overall, Fresenius Medical Care AG offers a comprehensive range of products and services for dialysis patients and is a significant player in the field of kidney care. The company is committed to improving the quality of life for patients with chronic kidney diseases and driving the development of innovative technologies and methods to treat this disease. Fresenius Medical Care is one of the most popular companies on Eulerpool.com.

Fresenius Medical Care revenue by segment

In the annual report of the Fresenius Medical Care share (DE0005785802, 578580, FME.DE), it breaks down its revenues into 4 segments: 1. North America, 2. EMEA, 3. Asia-Pacific, 4. Latin America. The Fresenius Medical Care stock (WKN: 578580, ISIN: DE0005785802, Ticker Symbol: FME.DE) is a leading investment for investors interested in participating in the Health Care sector.

  • 70 % North America

  • 15 % EMEA

  • 11 % Asia-Pacific

  • 4 % Latin America

Fresenius Medical Care SWOT Analysis

Strengths

Fresenius Medical Care AG is a global leader in the field of dialysis and renal care, with a strong market presence in over 120 countries. The company benefits from its extensive network of clinics and partnerships, allowing it to provide comprehensive and high-quality services to patients worldwide.

The company's strong financial performance and profitability are key strengths, enabling it to invest in research and development, expand its operations, and attract top talent. Fresenius Medical Care AG's strong brand reputation and recognized expertise further contribute to its competitive advantage in the market.

Weaknesses

Despite its global presence, Fresenius Medical Care AG may face challenges in certain regions due to regulatory and reimbursement constraints. Adapting to diverse regulatory environments and addressing pricing pressures can potentially hinder the company's growth and profitability.

As a specialized healthcare provider, Fresenius Medical Care AG's success heavily relies on the availability of skilled healthcare professionals, efficient supply chain management, and technological advancements. Any weaknesses in these areas may impact the company's ability to deliver consistent and high-quality care to its patients.

Opportunities

The increasing incidence of chronic kidney diseases and the rising aging population present significant growth opportunities for Fresenius Medical Care AG. As the demand for renal care services continues to grow, the company can expand its market share by offering innovative treatment options and enhancing patient experience.

Strategic collaborations and partnerships with healthcare providers, research institutions, and technology companies can also open up new avenues for Fresenius Medical Care AG to develop and deliver advanced dialysis solutions. Additionally, entering emerging markets with underserved renal care needs can fuel the company's expansion and revenue growth.

Threats

Fresenius Medical Care AG operates in a highly competitive industry, facing competition from both established players and emerging entrants. Pricing pressures and the potential loss of key contracts can pose threats to the company's market position and profitability.

Rapid advancements in medical technology and the potential disruption caused by new treatment methods or alternative therapies also present threats to the traditional dialysis market, requiring Fresenius Medical Care AG to adapt and innovate to stay ahead.

Fresenius Medical Care historical P/E ratio, EBIT, and P/S ratio.

Fresenius Medical Care shares outstanding

The number of shares was Fresenius Medical Care in 2023 — This indicates how many shares 293.413 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Fresenius Medical Care earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Fresenius Medical Care's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Fresenius Medical Care’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Fresenius Medical Care's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Fresenius Medical Care Stock splits

In Fresenius Medical Care's history, there have been no stock splits.

Fresenius Medical Care dividend history and estimates

In 2023, Fresenius Medical Care paid a dividend amounting to 1.12 EUR. Dividend means that Fresenius Medical Care distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Fresenius Medical Care provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Fresenius Medical Care’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Fresenius Medical Care's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Fresenius Medical Care Dividend History

DateFresenius Medical Care Dividend
2030e1.14 EUR
2029e1.14 EUR
2028e1.14 EUR
2027e1.14 EUR
2026e1.14 EUR
2025e1.14 EUR
2024e1.14 EUR
20231.12 EUR
20221.35 EUR
20212.69 EUR
20201.2 EUR
20191.17 EUR
20181.06 EUR
20170.96 EUR
20160.8 EUR
20150.78 EUR
20140.77 EUR
20130.75 EUR
20120.69 EUR
20110.65 EUR
20100.61 EUR
20090.58 EUR
20080.54 EUR
20070.47 EUR
20060.41 EUR
20050.37 EUR
20040.34 EUR

Fresenius Medical Care dividend payout ratio

In 2023, Fresenius Medical Care had a payout ratio of 56.8%. The payout ratio indicates the percentage of the company's profits that Fresenius Medical Care distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Fresenius Medical Care represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Fresenius Medical Care could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Fresenius Medical Care's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Fresenius Medical Care Payout Ratio History

DateFresenius Medical Care Payout ratio
2030e61.68 %
2029e61.5 %
2028e61.22 %
2027e62.32 %
2026e60.94 %
2025e60.4 %
2024e65.63 %
202356.8 %
202258.79 %
202181.3 %
202030.31 %
201929.52 %
201816.43 %
201723.08 %
201621.45 %
201524.92 %
201429.85 %
201328.2 %
201223 %
201125.59 %
201024.9 %
200927.23 %
200828.88 %
200726.26 %
200628.47 %
200529.86 %
200430.63 %
Unfortunately, there are currently no price targets and forecasts available for Fresenius Medical Care.

Fresenius Medical Care latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/20240.6 EUR0.82 EUR (37.28 %)2024 Q1
12/31/20230.94 EUR0.88 EUR (-6.11 %)2023 Q4
9/30/20230.52 EUR0.57 EUR (9.45 %)2023 Q3
6/30/20230.51 EUR0.6 EUR (16.93 %)2023 Q2
3/31/20230.52 EUR0.52 EUR (-0.29 %)2023 Q1
12/31/20220.79 EUR0.86 EUR (8.44 %)2022 Q4
9/30/20220.68 EUR0.79 EUR (15.77 %)2022 Q3
6/30/20220.83 EUR0.77 EUR (-7.3 %)2022 Q2
3/31/20220.7 EUR0.68 EUR (-2.5 %)2022 Q1
12/31/20210.88 EUR0.9 EUR (2.03 %)2021 Q4
1
2
3
4
5
...
9

Eulerpool ESG Scorecard© for the Fresenius Medical Care stock

Eulerpool World ESG Rating (EESG©)

96/ 100

🌱 Environment

99

👫 Social

99

🏛️ Governance

91

Environment

Scope 1 - Direct Emissions
258,400
Scope 2 - Indirect emissions from purchased energy
472,900
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
731,300
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
❌
Pesticides
❌
Palm Oil
❌
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
✅
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees69
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Fresenius Medical Care list of shareholders

%
Name
Stocks
Change
Date
5.20 % Pzena Investment Management, LLC15,257,49901/4/2024
5.02 % Harris Associates L.P.14,735,47201/4/2024
4.81 % Dodge & Cox14,122,9275,294,14412/31/2022
4.10 % BlackRock Institutional Trust Company, N.A.12,030,043011/8/2023
32.17 % Fresenius SE & Co KGaA94,380,38201/4/2024
2.99 % Artisan Partners Limited Partnership8,785,06201/2/2023
2.10 % The Vanguard Group, Inc.6,155,605124,8213/31/2024
1.05 % Fidelity International3,094,32202/29/2024
0.99 % Norges Bank Investment Management (NBIM)2,914,920-649,26612/31/2023
0.95 % Lazard Asset Management, L.L.C.2,778,30431,0193/31/2024
1
2
3
4
5
...
10

Fresenius Medical Care Executives and Management Board

Ms. Helen Giza55
Fresenius Medical Care Chairman of the Management Board, Chief Executive Officer
Compensation 3.21 M EUR
Dr. Katarzyna Mazur-Hofsaess59
Fresenius Medical Care Member of the Management Board, Chief Executive Officer - Care Enablement
Compensation 2.71 M EUR
Dr. Frank Maddux65
Fresenius Medical Care Member of the Management Board, Global Chief Medical Officer
Compensation 2.64 M EUR
Dr. Dieter Schenk71
Fresenius Medical Care Chairman of the Supervisory Board (since 1996)
Compensation 437,000 EUR
Mr. Rolf Classon78
Fresenius Medical Care Independent Vice Chairman of the Supervisory Board (since 2011)
Compensation 399,000 EUR
1
2
3

Most common questions regarding Fresenius Medical Care

What values and corporate philosophy does Fresenius Medical Care represent?

Fresenius Medical Care AG represents values of quality, innovation, and patient-centered care. With a dedicated corporate philosophy, the company focuses on providing life-saving dialysis products, therapies, and services to patients worldwide. The commitment to excellence, compassion, and continuous advancement in medical technology enables Fresenius Medical Care AG to enhance patients' quality of life and deliver optimal renal care. As a global leader in the field, Fresenius Medical Care AG maintains a strong emphasis on scientific research, sustainability, and delivering efficient healthcare solutions for patients suffering from chronic kidney diseases.

In which countries and regions is Fresenius Medical Care primarily present?

Fresenius Medical Care AG is primarily present in various countries and regions across the globe. With a strong global presence, the company operates in more than 150 countries and regions, including the United States, Germany, Asia-Pacific, Latin America, and Europe. Its widespread international network enables Fresenius Medical Care AG to provide advanced renal care products, services, and solutions to patients worldwide. As the global leader in dialysis and kidney care, Fresenius Medical Care AG continues to expand its reach and impact, ensuring quality healthcare for patients globally.

What significant milestones has the company Fresenius Medical Care achieved?

Fresenius Medical Care AG, a leading healthcare company, has achieved significant milestones throughout its history. It pioneered the development of advanced dialysis products and services, revolutionizing the treatment of end-stage renal disease. The company has established a global presence, operating in over 120 countries and serving millions of patients worldwide. Additionally, Fresenius Medical Care AG has continuously expanded its business through strategic acquisitions and collaborations, strengthening its position as a market leader in dialysis care. With a commitment to research and development, the company has achieved breakthrough innovations in dialysis technology, enhancing patient outcomes and quality of life. Overall, Fresenius Medical Care AG’s impressive achievements have solidified its reputation as a trusted provider of renal therapies.

What is the history and background of the company Fresenius Medical Care?

Fresenius Medical Care AG is a leading global healthcare company specializing in dialysis products and services. Established in 1996, it stemmed from the merger of Fresenius AG and National Medical Care. With its headquarters in Germany, the company has expanded its reach worldwide, operating in nearly 150 countries. Fresenius Medical Care AG is renowned for its expertise in renal therapy, offering innovative dialysis machines, dialyzers, and related medical supplies. As a market leader, it provides life-saving treatments to millions of people suffering from chronic kidney disease. The company's commitment to delivering high-quality care and advancing renal healthcare has made Fresenius Medical Care AG a trusted name in the medical industry.

Who are the main competitors of Fresenius Medical Care in the market?

The main competitors of Fresenius Medical Care AG in the market are DaVita Inc., Baxter International Inc., and B. Braun Melsungen AG.

In which industries is Fresenius Medical Care primarily active?

Fresenius Medical Care AG is primarily active in the healthcare industry.

What is the business model of Fresenius Medical Care?

Fresenius Medical Care AG is a leading global provider of dialysis products, services, and solutions for patients with chronic kidney failure. The company's business model revolves around providing high-quality dialysis care to patients in over 120 countries. Fresenius Medical Care AG offers a comprehensive range of dialysis machines, dialyzers, and other related products to ensure efficient and effective treatment. Furthermore, the company operates a network of dialysis clinics, providing personalized care for patients worldwide. With a focus on innovation, research, and development, Fresenius Medical Care AG continuously strives to enhance patient outcomes and improve the overall quality of life for individuals with kidney disease.

What is the P/E ratio of Fresenius Medical Care 2024?

The Fresenius Medical Care P/E ratio is 13.22.

What is the P/S ratio of Fresenius Medical Care 2024?

The Fresenius Medical Care P/S ratio is 0.55.

What is the AlleAktien quality score of Fresenius Medical Care?

The AlleAktien quality score for Fresenius Medical Care is 3/10.

What is the revenue of Fresenius Medical Care 2024?

The expected Fresenius Medical Care revenue is 19.81 B EUR.

How high is the profit of Fresenius Medical Care 2024?

The expected Fresenius Medical Care profit is 828.74 M EUR.

What is the business model of Fresenius Medical Care

Fresenius Medical Care AG is a leading provider of products and services for the dialysis treatment of patients with kidney failure. The company is headquartered in Bad Homburg, Germany, and operates in over 120 countries worldwide. Fresenius Medical Care also operates its own dialysis centers and offers various other medical services. The business model of Fresenius Medical Care includes three business segments: dialysis products, services related to dialysis treatment, and the care of patients with chronic diseases. In the field of dialysis products, Fresenius Medical Care develops and produces a wide range of dialysis equipment and reagents. These products are sold to both their own dialysis centers and other medical facilities worldwide. Thanks to technological innovations in dialysis treatment, medical professionals can offer patients better outcomes and a higher quality of life. In the second business segment, Fresenius Medical Care provides services related to dialysis treatment. The company operates and manages its own dialysis centers and also provides the necessary medical professionals. Additionally, Fresenius Medical Care offers technical support and training for the use of their own dialysis products. These services are an important part of the business model as they ensure both the sales of their own products and the high-quality medical care of patients. A third business segment of Fresenius Medical Care is the care of patients with chronic diseases. Through the use of data analysis and telemedicine technologies, medical professionals from Fresenius Medical Care can actively care for patients - both online and through home visits. The goal is to improve the health of patients and avoid hospital stays. The business model of Fresenius Medical Care is based on preventive health care and support for people with chronic diseases such as kidney failure. By providing high-quality products and services and establishing a comprehensive patient care program, Fresenius Medical Care strengthens its position as a leading provider in dialysis treatment. In recent years, Fresenius Medical Care has also increased its investment in research and development of innovative treatment methods to continuously improve the quality of medical care for patients with chronic diseases. The extensive expertise in this field enables the development of new treatment modalities, including digital solutions, that benefit patients. Overall, Fresenius Medical Care is an innovative company specializing in the provision of products and services for dialysis treatment. By combining technological innovations, a comprehensive patient care program, and a constant focus on the needs of medical professionals in the global healthcare industry, the company relies on a forward-looking, promising business model in a sector of growing importance.

What is the Fresenius Medical Care dividend?

Fresenius Medical Care pays a dividend of 1.35 EUR distributed over 1 payouts per year.

How often does Fresenius Medical Care pay dividends?

Fresenius Medical Care pays out a dividend 1 times a year.

What is the Fresenius Medical Care ISIN?

The ISIN of Fresenius Medical Care is DE0005785802.

What is the Fresenius Medical Care WKN?

The WKN of Fresenius Medical Care is 578580.

What is the Fresenius Medical Care ticker?

The ticker of Fresenius Medical Care is FME.DE.

How much dividend does Fresenius Medical Care pay?

Over the past 12 months, Fresenius Medical Care paid a dividend of 1.12 EUR . This corresponds to a dividend yield of about 3 %. For the coming 12 months, Fresenius Medical Care is expected to pay a dividend of 1.14 EUR.

What is the dividend yield of Fresenius Medical Care?

The current dividend yield of Fresenius Medical Care is 3 %.

When does Fresenius Medical Care pay dividends?

Fresenius Medical Care pays a quarterly dividend. This is distributed in the months of September, June, June, June.

How secure is the dividend of Fresenius Medical Care?

Fresenius Medical Care paid dividends every year for the past 33 years.

What is the dividend of Fresenius Medical Care?

For the upcoming 12 months, dividends amounting to 1.14 EUR are expected. This corresponds to a dividend yield of 3.06 %.

In which sector is Fresenius Medical Care located?

Fresenius Medical Care is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fresenius Medical Care kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fresenius Medical Care from 5/21/2024 amounting to 1.19 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did Fresenius Medical Care pay the last dividend?

The last dividend was paid out on 5/21/2024.

What was the dividend of Fresenius Medical Care in the year 2023?

In the year 2023, Fresenius Medical Care distributed 1.35 EUR as dividends.

In which currency does Fresenius Medical Care pay out the dividend?

The dividends of Fresenius Medical Care are distributed in EUR.

All fundamentals about Fresenius Medical Care

Our stock analysis for Fresenius Medical Care Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fresenius Medical Care Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.